WVA policies: Pharmaceutical Stewardship

Pharmaceutical Stewardship Pharmaceutical Stewardship

25 Aug 2023

WVA Position Statement In Opposition To International Scheduling Of Ketamine

The World Veterinary Association (WVA) strongly objects to international control of ketamine, as this could lead to ketamine being no longer available to veterinary and medical practitioners for clinical use..

Download document

One Health One Health

22 Sep 2020

List of Available Guidelines for Responsible use of Antimicrobials in Animal Health – Revision 6 – September 2020

The growing emergence of resistance to antimicrobials is a threat to humans, animals and the environment. This is an increasing global concern and many countries around the world have already taken measures to tackle the development of Antimicrobial Resistance (AMR).

Download document

Pharmaceutical Stewardship Pharmaceutical Stewardship

14 Mar 2019

WVA Position Statement on Availability of Veterinary Pharmaceuticals

Veterinary pharmaceuticals must be manufactured under strict guidelines and be licensed or registered and approved for use only after undergoing a rigorous quality assurance assessment that is regulated and evaluated by national or regional authorities.

Download document

One Health One Health

15 Nov 2018

WVA Position Statement on Animal Vaccination for Advancing Animal and Human Health

The WVA supports promoting the value of vaccinating animals to reduce the risk of infectious and zoonotic diseases by developing educational materials for use by veterinarians to increase client education surrounding appropriate vaccination programs, and collaborating with other health professions to ensure sufficient resources to advance scientific understanding of vaccine pharmacology and immunology.

Download document

Pharmaceutical Stewardship Pharmaceutical Stewardship

31 Aug 2015

Pharmaceutical Stewardship” – A Strategic Priority for the World Veterinary Association

Association held its strategic planning session in March of 2015, we identified pharmaceutical stewardship as one of five major priority issues for (at least) the next three years.

Download document